glp-1 agonists cardiovascular diseases disease continuum-GLP-1 action. Adapted from [46] Cardiovascular Protective Properties of GLP-1

J., Dmarco, L., Castelao, A

Some research suggests adding semaglutide (the active ingredient in Wegovy) to metformin may help improve blood sugar control and lead to more weight loss than metformin alone

Finally, while time-stratified and subgroup analyses provide valuable insights, they remain exploratory and should be interpreted with caution given the potential for multiple testing, limited power in certain strata, and the inherent arbitrariness of fixed time-windows

Proven Weight Loss: Clinical studies, including the SURMOUNT-1 trial, have shown that Mounjaro can help people with obesity (without diabetes) lose an average of 15% to over 20% of their body weight